CrushSCI.com
Journal Selection & Manuscript Polishing Services
ONCOGENE journal cover Medicine
Back to journal directory

Review Cycle Records

ONCOGENE

Springer SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
236.2Average days
238Median days
92Fastest days
397Longest days
4032025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

92 days

tRNA-derived small RNAs in tumor microenvironment remodeling: From mechanistic insights to therapeutic perspectives

AuthorsYaguang Zhang

Affiliations1. Laboratory of Gastrointestinal Tumor Epigenetics and Genomics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China

Source PDF DOI Publisher page
272 days

Furin sustains tumor-promoting signals in KRAS- and BRAF-mutated colorectal cancer by engaging the TGF-β1-COX-2 axis in a reciprocal regulatory network

AuthorsYiyang Liu; Géraldine Siegfried; Simon Pernot; Zongsheng He; Marta Martin Bornez; Sabine Tejpar; Fanny Castanet; Gregoire Desolneux; Serge Evrard; Torsten Steinmetzer; John W. M. Creemers; Abdel-Majid Khatib

Affiliations1. Laboratory of Biochemical Neuroendocrinology, Department of Human Genetics, KU Leuven, Leuven, Belgium; 2. University of Bordeaux, Bordeaux Institute of Oncology (BRIC)-UMR1312, Bordeaux, France; 3. Institut Bergonié, Bordeaux, France; 4. Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium; 5. Department of Pharmaceutical Chemistry, Philipps-University Marburg, Marburg, Germany

Source PDF DOI Publisher page
236 days

Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset

AuthorsJingyuan Wang; Joanne Xiu; Francesca Battaglin; Hiroyuki Arai; Shivani Soni; Wu Zhang; Richard M. Goldberg; Anthony F. Shields; Axel Grothey; Jimmy J. Hwang; John L. Marshall; Igor Astaturov; Benjamin A. Weinberg; Emil Lou; Michael Hall; Rachna T. Shroff; Moh’d Khushman; Mohamed E. Salem; Davendra P. S. Sohal; Aaron J. Scott; Matt Oberley; Tianshu Liu; Lin Shen; Heinz-Josef Lenz

Affiliations1. Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China; 2. Department of Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, USA; 3. Department of Oncology, Zhongshan Hospital (Xiamen), Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, Fudan University, Shanghai, China; 4. Caris Life Sciences, Phoenix, USA; 5. West Virginia University Cancer Institute, Morgantown, USA; 6. Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, USA; 7. West Cancer Center and Research Institute, Germantown, USA; 8. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, USA; 9. Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, USA; 10. Fox Chase Cancer Center, Philadelphia, USA; 11. University of Minnesota, Minneapolis, USA; 12. Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, USA; 13. Division of Hematology/Oncology, University of Arizona Cancer Center, Tucson, USA; 14. Medical Oncology, Washington University in St. Louis/Siteman Cancer Center, St. Louis, USA; 15. University of Cincinnati, Cincinnati, USA; 16. Division of Hematology and Oncology, Banner University of Arizona Cancer Center, Tucson, USA; 17. Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China

Source PDF DOI Publisher page
190 days

A truncated TNS3 isoform expressed in metastatic triple negative breast cancer stabilizes FAK and promotes lung metastasis

AuthorsTakao Morinaga; Shouko Hayama; Yuki Nakamura; Katsushige Kawase; Hideki Ikeda; Suguru Miyata; Megumi Mogi; Eri Katayama; Rikiya Nakamura; Masahito Kawazu

Affiliations1. Division of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan; 2. Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan; 3. Department of Otorhinolaryngology/Head & Neck Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan; 4. Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Source PDF DOI Publisher page
256 days

MTAP deficiency enhances collective metastasis in non-small cell lung cancer via WNT3A methylation

AuthorsYang Chen; Hongfei Yan; Ye Zhang; Qikun Lv; Ran Ren; Jiajun Wang; Lirong Yan; Yongpeng He; Kezuo Hou; Yunpeng Liu; Yongsheng Li; Xiaofang Che; Xuejun Hu

Affiliations1. Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China; 2. Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China; 3. Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China; 4. Clinical Cancer Research Center of Shenyang, The First Hospital of China Medical University, Shenyang, China; 5. Provincial Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China; 6. The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Heping District, Shenyang, China; 7. Department of Thoracic Surgery, the First Hospital of China Medical University, Shenyang, China; 8. Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.